INO:NASDAQ
Inovio Pharmaceuticals Inc
၁.၄၂ US$
arrow_downward
-၀.၆၀%(-၀.၀၀၈၆) 1D
နို ၁၆, GMT-၅ ၁၁:၃၁:၁၇ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
၁.၄၂ US$
High
၁.၄၈ US$
Low
၁.၃၇ US$
Mkt. cap
၂၆.၆၉ ကုဋေ
Avg. vol.
၁.၉၃ ကုဋေ
Volume
၂.၁၆ သန်း
52-wk high
၂.၇၂ US$
52-wk low
၀.၅၆ US$
EPS
-၀.၈၀ US$
Beta
၁.၇၁
Shares outstanding
၁၈.၇၃ ကုဋေ
No. of employees
၁၁၂
Open
၁.၄၂ US$
High
၁.၄၈ US$
Low
၁.၃၇ US$
Mkt. cap
၂၆.၆၉ ကုဋေ
Avg. vol.
၁.၉၃ ကုဋေ
Volume
၂.၁၆ သန်း
52-wk high
၂.၇၂ US$
52-wk low
၀.၅၆ US$
EPS
-၀.၈၀ US$
Beta
၁.၇၁
Shares outstanding
၁၈.၇၃ ကုဋေ
No. of employees
၁၁၂
News stories
From web sources and news partners
ChartMill
·
ပြီးခဲ့သည့် ၅၅ မိနစ်
S&P 500 Gap-Down Movers in Nov. 16, 2026 Session
Benzinga
·
ပြီးခဲ့သည့် ၃၁ မိနစ်
Here’s How Much You Would Have Made Owning iShares S&P 500 Growth ETF Stock In The Last 15 Years
MarketWatch
·
ပြီးခဲ့သည့် ၄၄ မိနစ်
These 13 S&P 500 stocks can rise up to 70% over the next year, according to analysts
Traders Union
·
ပြီးခဲ့သည့် ၅၆ မိနစ်
Peter Tuchman: S&P 500 loses over $800 billion in market cap
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc